Skip to main content
Figure 6 | Journal of Translational Medicine

Figure 6

From: HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy

Figure 6

Impact of HER2 gene amplification and HER2 and TOP2A mRNA expression on patient outcome. Kaplan-Meier curves for HER2 status (A, B), HER2 mRNA expression (C, D) and TOP2A mRNA expression (E, F) in terms of disease-free (DFS) and overall survival (OS). Comparisons by log-rank test. Red lines: positive or high; Blue lines: negative or low.

Back to article page